MREO MEREO BIOPHARMA GROUP PLC: institutional ownership and insider trading
60 funds reported holding $18.3M of MEREO BIOPHARMA GROUP PLC in their latest 13F filings; in Q2 2026 funds net sold $6.00M, with 12 new positions and 17 funds selling out.
Famous investors holding MREO
- Two Sigma (Two Sigma Investments): $419K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $318K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $16.6K, 0.0% of the portfolio
Largest institutional holders of MREO
- Rubric Capital Management LP — $4.86M
- 683 Capital Management, LLC — $3.74M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $2.60M
- Defilade Capital Management, L.P. — $2.40M
- Newtyn Management, LLC — $953K
- Tejara Capital Ltd — $647K
- UBS Group AG (UBS) — $460K
- TWO SIGMA INVESTMENTS, LP — $419K
- CITADEL ADVISORS LLC — $318K
- EcoR1 Capital, LLC — $318K
Who owns the most MREO stock?
The largest institutional holders of MEREO BIOPHARMA GROUP PLC in the latest 13F filings are Rubric Capital Management LP ($4.86M), 683 Capital Management, LLC ($3.74M), BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) ($2.60M).
Which famous investors own MREO?
Two Sigma, Ken Griffin, Renaissance Technologies.